Jessica M Stempel

10PUBLICATIONS
66CO-AUTHORS
Regenerative medicine (incl. stem cells)HaematologyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Forensic epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Dec 03, 2025
Calcineurin inhibitor and eltrombopag combination for acquired aplastic anemia: results from a large national database.

Jessica M Stempel, Rong Wang, Alfred I Lee

|Sep 18, 2025
Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis.

Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles

|Aug 14, 2025
Advances and Challenges in the Management of Myelodysplastic Syndromes.

Jessica M Stempel, Tariq Kewan, Amer M Zeidan

|Jul 28, 2025
Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML.

Abdulrahman Alhajahjeh, Kishan K Patel, Nikolai A Podoltsev

|May 31, 2025
Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial.

Vivek G Patel, Karine Tawagi, Samantha A Armstrong

Pageof 2

Frequent Collaborators

4 joint publications

Nikolai A Podoltsev

3 joint publications

Abdulrahman Alhajahjeh

3 joint publications

Lourdes Mendez

2 joint publications

Rory M Shallis